Poordad, Fred

Publishing since 2007 (Baby)

Has published 8 publications in 4 years

Number of publications published per year by Poordad, Fred. (Source : PubMed)

Distribution of publications types for Poordad, Fred. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Rifaximin treatment in hepatic encephalopathy.  N. Engl. J. Med.  2010;362;12  
•  Chang TT, Lai CL, Kew Yoon S, Lee SS, Coelho HS, Carrilho FJ, Poordad F, Halota W, Horsmans Y, Tsai N, Zhang H, Tenney DJ, Tamez R, Iloeje U. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.  Hepatology  2010;51;2  
•  Tran TT, Rakoski MO, Martin P, Poordad F. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.  Aliment. Pharmacol. Ther.  2010;31;2  
•  Gish RG, Chang TT, Lai CL, de Man R, Gadano A, Poordad F, Yang J, Brett-Smith H, Tamez R. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.  J. Viral Hepat.  2010;17;1  
•  Rustgi VK, Lee WM, Lawitz E, Gordon SC, Afdhal N, Poordad F, Bonkovsky HL, Bengtsson L, Chandorkar G, Harding M, McNair L, Aalyson M, Alam J, Kauffman R, Gharakhanian S, McHutchison JG. Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.  Hepatology  2009;50;6  
•  Oh MK, Winn J, Poordad F. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.  Aliment. Pharmacol. Ther.  2008;28;5  
•  Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia associated with chronic liver disease.  J. Hepatol.  2008;48;6  
•  Poordad F, Reddy KR, Martin P. Rapid virologic response: a new milestone in the management of chronic hepatitis C.  Clin. Infect. Dis.  2008;46;1  
•  Poordad F. Review article: thrombocytopenia in chronic liver disease.  Aliment. Pharmacol. Ther.  2007;26 Suppl 1  
•  Shaye OA, Yadegari M, Abreu MT, Poordad F, Simon K, Martin P, Papadakis KA, Ippoliti A, Vasiliauskas E, Tran TT. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.  Am. J. Gastroenterol.  2007;102;11  

[ See timeline ] [ See all publications ]